Vascudyne, Inc.
Vascudyne is developing, manufacturing and commercializing regenerative acellular in-vitro grown “allograft” tissue. We are visionaries and realists in the right proportions. We are after the holy grail of bringing tissue-engineered medical products to patients AND have a deep bench of expertise in what it takes to run a successful medical device company.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Supplies
- Market Focus:
- Nationally (across the country)
Our Story
Vascudyne was founded by Jeff Franco and Kem Schankereli after a successful exit from Tendyne. Tendyne was a transcatheter mitral valve company that was acquired by Abbott in 2015 for $400 Million. Vascudyne leadership brings unique and minimally invasive delivery expertise alongside stent design technology for cardiovascular devices.
After evaluating several biomaterial technologies, Vascudyne picked a winner: the regenerative engineered tissue technology developed by Professor Robert Tranquillo and his team at the University of Minnesota.
Dr. Robert Tranquillo, Distinguished McKnight University Professor, and his team have been developing and fine-tuning the engineered tissue technology for decades, establishing its unique properties and regenerative potential. Professor Tranquillo along with key team member Dr. Zeeshan Syedain and colleagues have demonstrated the distinct advantages engineered tissue technology holds over existing therapies in a plethora of peer-reviewed publications of in vitro and pre-clinical in vivo studies.
Vascudyne licensed the engineered tissue technology from the University of Minnesota in December of 2018 and has been on a mission to accelerate its commercialization and get the technology out of the lab and into the hands of surgeons to benefit the millions of patients in need of replacement and repair tissues.
Dr. Zeeshan Syedain joined Vascudyne as its Chief Scientific Officer in 2021 in perfect alignment with the company’s mission: to improve patient care with regenerative biomaterials that are inspired by nature. And that is what Vascudyne is developing: TRUE Tissue technology that is inspired by nature.
Our Facilities
As an experienced team startup, we pride ourselves in right-sizing our facilities and investing in accomplishing critical milestones. Our manufacturing facilities feature state-of-the-art equipment for cell harvesting from human foreskin tissue, cell expansion, tissue development and maturation, and TRUE™ Tissue storage. Onsite cell and tissue characterization and mechanical testing instruments allow us to quickly and efficiently evaluate cell and tissue properties and perform validation testing and quality control. The facility is operated under cGMP standards paving the path for full compliance.